SynthesisInfectious diseases of poverty2026
Global distribution, clinical characteristics, and outcomes of human intestinal capillariasis, 2000-2025: a systematic review.
Synthesis in Infectious diseases of poverty, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIntestinal capillariasis, caused by Capillaria philippinensis, is an uncommon but potentially fatal parasitic infection associated with the consumption of raw or undercooked freshwater fish. Despite its sporadic occurrence, its clinical severity and diagnostic challenges warrant a comprehensive synthesis of available evidence. This systematic review aimed to summarize the geographic distribution, risk factors, clinical manifestations, diagnostic approaches, and treatment outcomes of human intestinal capillariasis.
methodsA systematic search of six electronic databases (PubMed, Scopus, EMBASE, Web of Science, Nursing & Allied Health Premium, Ovid) was conducted to identify studies published between January 2000 and August 2025. Eligible studies included case reports, case series, and observational studies investigating C. philippinensis infection in humans. Study selection was performed independently by two reviewers, while data extraction was conducted by one reviewer using a standardized template and independently verified by a second reviewer, with discrepancies resolved through discussion. Data were extracted and synthesized narratively following the PRISMA 2020 guidelines.
resultsThirty-two studies involving 348 patients were included, comprising studies from Asia (25/32), Africa (6/32), and South America (1/32). The burden of intestinal capillariasis was high in symptomatic or high-risk groups (5.0-23.0%) but extremely low (< 0.01%) in community-based or routine screening populations. Consumption of raw or undercooked freshwater fish was consistently identified as the principal risk factor. Clinical features were highly consistent across studies, characterized by chronic watery diarrhea, abdominal pain, weight loss, and peripheral edema. Hypoalbuminemia was the hallmark laboratory abnormality, frequently accompanied by electrolyte disturbances and anemia. Diagnosis relied primarily on stool microscopy, although limited sensitivity often required repeated examinations; histopathology and polymerase chain reaction provided important adjunctive confirmation in selected cases. Co-infections with other intestinal parasites were commonly reported. Treatment with albendazole or mebendazole was generally effective, with comparable outcomes between agents; however, delayed diagnosis was associated with severe complications and occasional mortality.
conclusionsIntestinal capillariasis is an underrecognized foodborne infection with a consistent clinical and laboratory profile across study designs. Early diagnosis through repeated stool examination and timely treatment with benzimidazoles is critical to improving outcomes. Strengthening food safety practices and enhancing surveillance are essential to reduce disease burden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.